PubMed · 1990 · 53 citations · 6 references
MedicineDermatologyOncologyCutaneous OncologyDermatologic SurgeryPhotodermatologyBasal Cell CarcinomaNeoplastic Skin LesionsPhotodynamic TherapySkin TumorsCancer Photodynamic TherapyDermatologic Photodynamic TherapyPhotosensitizing CompoundsSkin Tumor TreatmentSuperficial Basal Cell CarcinomaTreatment Modality Selection
The efficacy of an originally developed photodynamic approach, using topical administration of tetraphenylporphinesulfonate as the photosensitizer, was evaluated in a series of 292 basal cell carcinoma lesions (less than 2-mm thick) in 50 treated patients. The lack of indication for conventional therapies was the main selection criterion. The photosensitizing agent (2% solution) was topically applied at 0.1 ml/cm2, followed by light irradiation with a dye laser emitting at 645 nm (120 or 150 J/cm2). After initial treatment, all lesions responded, with 273 (93.5%) complete responses. Recurrences were observed in 29 (10.6%). A second application of photoradiation was performed in 15 persistent lesions and 11 relapsed lesions, producing 19/26 complete responses. Our results suggest that this technique can be considered a promising alternative treatment modality in selected cases of superficial basal cell carcinomas.
6
Photoradiation therapy for the treatment of malignant tumors.
Thomas J. Dougherty, J. Kaufman, Abraham Goldfarb et al. · PubMed · 1978 · 1.5K citations
Medicine, Dermatology, Oncology +13
Laser photoradiation therapy of cancer.
Anton Dahlman, Wile Ag, Burns Rg et al. · PubMed · 1983 · 185 citations
Medicine, Dermatology, Oncology +13